… rationale as a therapeutic target in COVID-19. Data extracted from the COVID-19 Global …
a significant association between anti-TNF-α therapy and hospitalization length [78]; on these …

… between immune responses and COVID-19, immune characteristics are now … therapeutic
targets for COVID-19. In this review, we summarize the immune characteristics of COVID-19 …

… In conclusion, the treatment strategy for patients with COVID-19 should be carefully designed
based on both viral kinetics and immunopathogenesis. However, pandemic infection with …

… potently active during the immunopathogenic ARDS phase of COVID-19 disease, suggesting
that … A number of drugs and combinational therapies have been identified using previously …

… in the immunopathogenesis of COVID-19. In addition to this, we also highlight various
therapeutic options already in use such as immunosuppressive drugs, plasma therapy and …

… therapeutic role of extracorporeal cytokine removal to treat the cytokine storm associated
with COVID-19. … in COVID-19, this study provides a possible therapeutic approach to treating …

… knowledge of COVID-19 immunopathogenesis is crucially … of patients with COVID-19
provide valuable information with … for the use of complement inhibition as therapy in COVID-19. …

… the mechanisms of the immune response and the balance between pro-inflammatory
and anti-inflammatory response patterns to understand the immunopathogenesis of COVID-19. …

… immunopathogenesis of SARS-CoV-2 in humans and to provide insight into more effective
therapeutic … Here, we describe the immune responses and immunopathogenesis of COVID-19…

… the high virulence capacity of COVID-19 will help in potential targeted therapy against it. “…
novel COVID-19. Moreover, our review mainly focuses on the most state-of-the-art therapeutic …